Morepen Laboratories Ltd (NSE:MOREPENLAB)
₹ 79.16 -1.09 (-1.36%) Market Cap: 43.43 Bil Enterprise Value: 44.43 Bil PE Ratio: 45.81 PB Ratio: 3.48 GF Score: 74/100

Q3 2025 Morepen Laboratories Ltd Earnings Call Transcript

Feb 6, 2025 / 10:00 AM GMT
Release Date Price: ₹62.68 (-6.00%)

Key Points

Positve
  • Morepen Laboratories Ltd (BOM:500288) reported a 6.5% revenue growth for the nine months, indicating a steady performance despite challenging market conditions.
  • The company's profit before tax increased by 39%, and profit after tax rose by 44%, showcasing improved profitability.
  • The European market showed a significant 55% jump in revenue, contributing positively to the company's overall performance.
  • The medical devices segment experienced a 15% growth in the quarter, with glucometers and BP monitors being the main contributors.
  • The company has completed the civil work for its new medical device facility, which will enhance production capacity and support future growth.
Negative
  • The US market experienced a slowdown, with a 14% decline in sales due to political and economic uncertainties.
  • The company's margins were temporarily impacted by rising raw material costs and stagnant finished product prices.
  • The Pharma business showed only a 5% growth over nine months, indicating a need for stronger performance in this segment.
  • The domestic market saw a 5% decline in sales, reflecting challenges in maintaining growth within India.
  • The company faces competitive pressures in the B2B segment, particularly from aggressive pricing by Chinese competitors.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MORL.NS - Morepen Laboratories Ltd
Q3 2025 Morepen Laboratories Ltd Earnings Call
Feb 06, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day. And welcome to Moip Laboratories Limited Q3 FY25 earnings conference call hosted by Motilal Oswal Financial Services Limited.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call? Please signal an operator by pressing the star then zero on your touchtone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr Tal Manu from moti Financial Services Limited. Thank you and over to you, sir.

--------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot